267 related articles for article (PubMed ID: 19610266)
1. Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab.
Galera C; Soohun N; Zankar N; Caimmi S; Gallen C; Demoly P
J Investig Allergol Clin Immunol; 2009; 19(3):225-9. PubMed ID: 19610266
[TBL] [Abstract][Full Text] [Related]
2. Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.
Palgan K; Bartuzi Z; Gotz-Zbikowska M
Int J Immunopathol Pharmacol; 2014; 27(1):109-12. PubMed ID: 24674685
[TBL] [Abstract][Full Text] [Related]
3. Anaphylaxis after Hymenoptera sting without detectable specific IgE.
Zidarn M; Kosnik M; Drinovec I
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Mar; 16(1):31-3. PubMed ID: 17992452
[TBL] [Abstract][Full Text] [Related]
4. Systemic and local reactions of bee venom immunotherapy in Iran.
Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
[TBL] [Abstract][Full Text] [Related]
5. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome.
da Silva EN; Randall KL
J Allergy Clin Immunol Pract; 2013; 1(6):687-8. PubMed ID: 24565720
[No Abstract] [Full Text] [Related]
7. [Intolerance of specific immunotherapy with Hymenoptera venom: jumping the hurdle with omalizumab].
Wieczorek D; Kapp A; Wedi B
Hautarzt; 2014 Sep; 65(9):791-5. PubMed ID: 25234627
[TBL] [Abstract][Full Text] [Related]
8. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
9. Failure of omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy.
Soriano Gomis V; Gonzalez Delgado P; Niveiro Hernandez E
J Investig Allergol Clin Immunol; 2008; 18(3):225-6. PubMed ID: 18564638
[No Abstract] [Full Text] [Related]
10. Hymenoptera venom allergy.
Przybilla B; Ruëff F
J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy against hymenoptera venom: report of ten patients].
Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
[TBL] [Abstract][Full Text] [Related]
12. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
Fricker M; Helbling A; Schwartz L; Müller U
J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
Stritzke AI; Eng PA
Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
[TBL] [Abstract][Full Text] [Related]
14. Case report of venom immunotherapy for a patient with large local reactions.
Hamilton RG; Golden DB; Kagey-Sobotka A; Lichtenstein LM
Ann Allergy Asthma Immunol; 2001 Aug; 87(2):134-7. PubMed ID: 11527245
[TBL] [Abstract][Full Text] [Related]
15. Jessner lymphocytic infiltrate as a side effect of bee venom immunotherapy.
Yalcin AD; Bisgin A; Akman A; Erdogan G; Ciftcioglu MA; Yegin O
J Investig Allergol Clin Immunol; 2012; 22(4):308-9. PubMed ID: 22812210
[No Abstract] [Full Text] [Related]
16. Systemic reactions during maintenance immunotherapy with honey bee venom.
Bousquet J; Ménardo JL; Velasquez G; Michel FB
Ann Allergy; 1988 Jul; 61(1):63-8. PubMed ID: 3389573
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and biological surveillance after the cessation of Hymenoptera venom desensitization].
Touraine F; Talayrach D; Florea O; Brianchon Ch; Preux PM; Bonnaud F
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):335-9. PubMed ID: 14716961
[TBL] [Abstract][Full Text] [Related]
18. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
Ruiz B; Serrano P; Moreno C
J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
[TBL] [Abstract][Full Text] [Related]
19. Human albumin causes anaphylaxis during bee venom immunotherapy.
Nakonechna A; Abuzakouk M
Ann Allergy Asthma Immunol; 2014 Jun; 112(6):559-60. PubMed ID: 24785838
[No Abstract] [Full Text] [Related]
20. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
